Basking Ridge, NJ, United States of America

Kung-I Feng


Average Co-Inventor Count = 9.9

ph-index = 1


Company Filing History:


Years Active: 2011-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Kung-I Feng in Basking Ridge, NJ

Introduction:

Inventor Kung-I Feng, based in Basking Ridge, NJ, has made significant contributions to the field of pharmaceuticals with his inventive spirit and dedication. With a total of 2 patents to his name, Kung-I Feng's work has not gone unnoticed in the industry.

Latest Patents:

1. Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof: This patent revolves around novel Pseudopolymorphs of Compound A, useful for treating or preventing HCV infections in patients.

2. Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound: This patent focuses on a compound for treating upper and lower obstructive airway diseases, highlighting the synthesis of polymorphic forms.

Career Highlights:

Kung-I Feng has showcased his expertise at prominent pharmaceutical companies like Merck Sharp & Dohme Corporation and Schering Corporation. His innovative approach and commitment to excellence have been instrumental in the development of groundbreaking pharmaceutical solutions.

Collaborations:

Throughout his career, Kung-I Feng has collaborated with esteemed professionals in the field, including Michael J McNevin and Yong Liu. Together, they have worked on cutting-edge projects that have pushed the boundaries of pharmaceutical research.

Conclusion:

In conclusion, Kung-I Feng's inventive prowess and collaborative efforts have left a lasting impact on the pharmaceutical industry. His patents and career highlights reflect a passion for innovation and a commitment to advancing healthcare solutions. Kung-I Feng stands as a testament to the power of creativity and dedication in driving meaningful change in the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…